Evotec Se Stock Price, News & Analysis
Company Description
Evotec Se (OTC Link: EVOTF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $1.3B.
EVOTF stock has declined 38.9% over the past year. Shares last traded at $5.24.
This page provides a comprehensive overview of EVOTF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Evotec Se (EVOTF) stock last traded at $5.24. Over the past 12 months, the stock has lost 38.9%. At a market capitalization of $1.3B, EVOTF is classified as a small-cap stock with approximately 177.6M shares outstanding.
Latest News
Evotec Se has 7 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include partnership, earnings, covid-19. View all EVOTF news →
SEC Filings
Evotec Se has filed 5 recent SEC filings, including 2 Form 6-K, 1 Form 20-F, 1 Form SCHEDULE 13D/A, 1 Form SCHEDULE 13D. The most recent filing was submitted on April 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all EVOTF SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Evotec Se (EVOTF) currently stands at 1.1 million shares, up 5.4% from the previous reporting period, representing 0.7% of the float. Over the past 12 months, short interest has increased by 27.9%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Evotec Se (EVOTF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 320.7 to 1000.0 days.
EVOTF Company Profile & Sector Positioning
Evotec Se (EVOTF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing EVOTF often look at related companies in the same sector, including Trulieve Cannabis Corp (TCNNF), Nika Pharmaceuticals (NIKA), Endo Inc (NDOI), Green Thum (GTBIF), and Elite Pharmaceuticals Inc (ELTP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EVOTF's relative position within its industry.